Advertisement

Topics

Genmab Inc. Company Profile

08:06 EDT 19th June 2018 | BioPortfolio

Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products. At present, Genmab has multiple partnerships to gain access to disease targets and develop novel human antibodies including agreements with Roche and Amgen. A broad alliance provides Genmab with access to Medarex, Inc.’s array of proprietary technologies, including the UltiMAb® platform for the rapid creation and development of human antibodies to virtually any disease target. Genmab is an international company with operations in Europe and the United States.

Location

457 North Harrison Street
Princeton
New Jersey
08540
United States of America

Contact

Phone: 1 609 430-2481
Fax: 1 609 430-2482
Email: info@genmab.com


News Articles [53 Associated News Articles listed on BioPortfolio]

Genmab A/S: Genmab 2017 Annual Report

Company AnnouncementCopenhagen, Denmark; February 21, 2018 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017. Below is a summary of business progress and financial pe...

Genmab A/S: Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference

Media ReleaseCopenhagen, Denmark; January 2, 2018 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual J.P....

Novartis Takes Genmab’s Leukemia Drug Off the Market

Genmab’s leukemia drug will be available around the world through compassionate use programs, while it will continue to be marketed as normal in the US. Blockbuster drug owner Genmab develope...

Genmab and Janssen Suffer Combination Therapy Setback

Janssen will discontinue a Phase I study testing Danish biotech Genmab’s blood cancer blockbuster daratumumab combined with a candidate checkpoint inhibitor in patients with multiple myeloma.  ...

Genmab hits roadblock in non-Hodgkin lymphoma

Results from a Phase 3 study of Arzerra didn't turn up positive for Genmab and partner Novartis, dimming prospects for the cancer biologic. 

Genmab stumbles after J&J dumps Darzalex combo trial

After an imbalance of patient deaths in a combo study of Darzalex and Tecentriq, Genmab partner Janssen is re-evaluating further combo studies. 

Genmab and Johnson & Johnson Halt Lung Cancer Study

Genmab A/S, and Johnson & Johnson’s Janssen division have pulled the plug on the Phase Ib/II trial of daratumumab in combination with Roche’s Tecentriq.

Genmab receives approval for its treatment for newly diagnosed multiple myeloma

Biotechnology company, Genmab, has announced that the FDA has approved the use of DARZALEX (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) for the treatment of patients wi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Genmab Inc.

Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat c...

Genmab A/S

Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Den...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

More Information about "Genmab Inc." on BioPortfolio

We have published hundreds of Genmab Inc. news stories on BioPortfolio along with dozens of Genmab Inc. Clinical Trials and PubMed Articles about Genmab Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genmab Inc. Companies in our database. You can also find out about relevant Genmab Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record